Skip to content
MedsAcross

Brand family

Cabometyx

United States
Presentations
3
Markets
1

Cabometyx is a brand of Cabozantinib s-malate marketed by Exelixis, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Cabozantinib s-malate
Brand owner
Exelixis
Registered in
United States
Strengths and forms
20 mg tablet, 40 mg tablet, 60 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Cabometyx 20 mg tabletOralExelixisUS FDAAvailable on request
Cabometyx 40 mg tabletOralExelixisUS FDAAvailable on request
Cabometyx 60 mg tabletOralExelixisUS FDAAvailable on request

Equivalent brands

Other brands of Cabozantinib s-malate.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Cabometyx

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.